Stocks Trending: Sears Hometown and Outlet Stores (NASDAQ:SHOS), Groupon (NASDAQ:GRPN), CTI BioPharma Corp. (NASDAQ:CTIC), Infinera Corporation (NASDAQ:INFN)

Posted by on Apr 29, 2016

Supercom Ltd (NASDAQ:SPCB) shares decreased -2.67% in last trading session and ended the day at $4.01. SPCB Gross Margin is 70.30% and its has a return on assets of 12.00%. Supercom Ltd (NASDAQ:SPCB) quarterly performance is -20.59%.

Supercom Ltd (NASDAQ:SPCB) announced that it has acquired the business of PowaPOS
, the developer of a fully-integrated mobile and tablet-based system integrating industry-leading retail and secure payment solutions into one simplified, attractive and innovative POS platform.

Sears Hometown and Outlet Stores, Inc. (NASDAQ:SHOS) ended the last trading day at $6.68. Company weekly volatility is calculated as 2.87% and price to cash ratio as 8.42. Sears Hometown and Outlet Stores, Inc. (NASDAQ:SHOS) showed a weekly performance of -1.04%.

On 19 April, Sears Hometown and Outlet Stores, Inc. (NASDAQ:SHOS) is opening its newest Virginia Sears Hometown Store inside LOVET Furniture located in the Hayes Plaza Shopping Center at 2352 George Washington Memorial Highway.

Groupon, Inc. (NASDAQ:GRPN) shares fell -3.90% in last trading session and ended the day at $4.43. GRPN Gross Margin is 44.40% and its has a return on assets of 1.00%. Groupon, Inc. (NASDAQ:GRPN) quarterly performance is 64.68%.

CTI BioPharma Corp. (NASDAQ:CTIC) caters to the Healthcare space. Its weekly performance is -5.96%. On the last day of trading company shares ended up at $0.53. CTI BioPharma Corp. (NASDAQ:CTIC) distance from 50-day simple moving average (SMA50) is -5.08%.
Groupon, Inc. (NASDAQ:GRPN) has named former Orbitz Worldwide chief financial officer Mike Randolfi as CFO.

On 20 April, CTI BioPharma Corp. (NASDAQ:CTIC) provides an overview of the CTI BioPharma Corp ’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for CTI BioPharma Corp, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

Infinera Corporation (NASDAQ:INFN) caters to the Technology space. It has a net profit margin of 5.80% and weekly performance is -18.50%. On the last day of trading company shares ended up at $12.01. Infinera Corporation (NASDAQ:INFN) distance from 50-day simple moving average (SMA50) is -21.91%.

On 27 April, Infinera Corporation (NASDAQ:INFN) released financial results for the first quarter of 2016 ended March 26, 2016. GAAP revenue for the quarter was $244.8 million compared to $260.0 million in the fourth quarter of 2015 and $186.9 million in the first quarter of 2015.

Leave a Reply

Your email address will not be published. Required fields are marked *